Cannabinoids

Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome

U.S. Court Says This Cannabinoid Is Legal, Rejects DEA's Position On Controlled Substances

Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country

U.S. Court Says This Cannabinoid Is Legal, Rejects DEA's Position On Controlled Substances

Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country

From Bars To Homes: Cannabis Beverages Redefine Drinking Culture

Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method

From Bars To Homes: Cannabis Beverages Redefine Drinking Culture

Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method

Why Does Tangie Smell So Fruity? Non-Terpene Compounds Include Guava, Papaya And Passionfruit

Japanese Cannabis Reform Is Almost Here

Cannabinoids Recent News

This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday its financial results for the full year and three months ended Dec. 31, 2023. Net revenue grew to CA$33 million ($24.3 million), from CA$22.1 million in 2022, representing roughly a 50% year-over-year increase. "Over the years we have invested in our infrastructure as a high quality and high-capacity pharmaceutical grade manufacturer, allowing us to grow sales with new opportunities and markets, without additional investment into capital or resources," David Pidduck said. "We are proud of the work completed in 2023 and excited about the future of MediPharm Labs."

High Hopes: Solid THC Revolution Takes Off At Brains Bioceutical

Brains Bioceutical Corp announces a breakthrough in medicine with the creation of solid THC, transforming cannabinoid-based treatments worldwide.

Marijuana's Prohibition Promotes Unregulated Weed Use, Study Finds

This article was originally published on MG Magazine and appears here with permission.

Rescheduling, Delta-8, Credit Cards To Buy Weed - And More Cannabis Industry Predictions For 2024

This article was originally published on Cannabis.net and appears here with permission. A lot went down this year for the cannabis industry.

Why Doesn't Smoking Medical Marijuana Make Sense? Expert Talks About Other Beneficial Consumption Methods

As the cannabis industry slowly develops and clears its name from decades of mysterious disrepute, scientists are figuring out many of the unknowns about this wondrous plant and its effects on humans.

Cannabinoids CBDA And CBGA Could Be Used As Basis For Natural Pesticides, Cornell Research Finds

Cannabinoids found in hemp could be used as the basis for natural pesticides, a new study by Cornell University researchers showed.</

Kicking Opioids For Cannabis? Navigating Kidney Disease Pain Management

This article was originally published on The Fresh Toast and appears here with permission

Exploring Cannabis For Cancer: Hope, Hype Or Healing? The Latest Research And Treatment Options

This article was originally published on Grassdoor and appears here with permission.

Nasdaq Grants SpiSparc, Ltd. Extension To Maintain Listing: +600% Bid Price Surge Needed

Specialty clinical-stage biopharma company SciSparc Ltd. (NASDAQ: SPRC) has received a Nasdaq notice granting the company an additional 180-day compliance period until March 4 to regain compliance with the stock market’s minimum bid price rule.

Does Marijuana Dehydrate You?

This article was originally published on The Fresh Toast and appears here with permission. The temperatures are soaring and people are sweltering under record heat and trapped smoke from wildfires. Sticky clothing, irritable moods and hot cars seem to be on the menu this summer.

DEA Weighs In On Legality Of THCA, Delta-8 And Other Minor Cannabinoids

The Drug Enforcement Administration is currently considering and evaluating its legal position surrounding cannabinoids such as THCA, delta-8 THC and hydrogenated CBD, reported Marijuana Moment.

Worms Get The Munchies Like The Rest Of Us, Finds Study 'With Profound Implications For Human Health'

A new study has confirmed that pot-smoking bipeds are not the only creatures that get the munchies. Worms apparently experience cravings for their favorite snacks after consuming cannabis.

What Are Cannabinoids, Their Types, And Effects?

This article was originally published on Askgrowers and appears here with permission.

We Need Hemp-Based Fiber, Food And Building Materials, Not Just CBD, Says Industry Report

Hemp hemp has three major markets, fiber, grain and building materials so why does CBD get all the attention? According to the Hemp Industry 2023 Opportunities Report, published by Let’s Talk Hemp,&nb

Cannabis With Enhanced Amounts Of THC (17%), CBG (25%) And Terepens (30%): Researchers Found A Way To Do It

This article was originally published in May 2022. Can cannabinoid content in the cannabis plant be manipulated? And if so, how much?

Understanding THC And TAC On Cannabis Labels

This article was originally published on The Fresh Toast and appears here with permission. When you’re shopping for a cannabis product, you should definitely take the percentage of TAC into account in addition to the THC in order to make an informed decision. Here’s why.

New Oral Film Tech Improving Cannabinoid Onset Seeks Patent Protection

Pharmaceutical films leader IntelGenx Corp. (OTCQB: IGXT) filed a provisional patent application with the U.S.

What's In Your Weed? A Look At The Most Abundant Cannabinoids, From THC And CBD To CBG And Others You've Never Heard Of

This article was originally published on Goldleaf, and appears here with permission. Introduction Everyone fascinated by the science behind cannabis is familiar with two of the most common cannabinoids: THC and CBD.

New Study Shows Promising Results In Treatment Of Parkinson's Disease With Cannabinoids

Biopharmaceutical research and drug development company, Gb Sciences, Inc. (OTCQB: GBLX), co-published a study in the journal Frontiers in Pharmacology that demonstrates the efficacy of its proprietary cannabinoid-containing, minimum essential mixtures for the treatment of Parkinson's disease.

Cannabinoids & Autism Spectrum Disorder: This Baltimore Company Is On Track To Start Phase 2 Clinical Trial For New Treatment

Cannabinoid-focused biopharmaceutical company Greater Cannabis Company, Inc. (OTC: GCAN) has submitted a clinical trial application to the Israel Ministry of Health for approval of Phase 2 clinical trial for its novel neuropsychiatric cannabinoid therapy.

Cannabis' Medicinal Properties And Lower Covid Hospitalizations: Is There A Connection? Here's What A New Study Found

A new study found that "cannabis consumption is associated with lower COVID-19 severity among hospitalized patients."

10+ Non-Marijuana Plants, Herbs And Shrooms That Contain Cannabinoids

This article was originally published on 2Fast4Buds and appears here with permission.

Botanical Ingredient Producer Linnea SA Celebrates 40 Years

The global cannabinoid market is projected to grow from $28.26 billion in 2021 to $197.74 billion in 2028 at a compound annual growth rate, CAGR, of 32.04%. One mature and seasoned company that entered the market in 2016 is Linnea SA.